These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 39446698)

  • 1. Development and longevity of naturally acquired antibody and memory B cell responses against Plasmodium vivax infection.
    Thawornpan P; Kochayoo P; Salsabila ZZ; Chootong P
    PLoS Negl Trop Dis; 2024 Oct; 18(10):e0012600. PubMed ID: 39446698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acquisition of long-lived memory B cell responses to merozoite surface protein-8 in individuals with Plasmodium vivax infection.
    Kochayoo P; Kittisenachai N; Changrob S; Wangriatisak K; Muh F; Chootong P; Han ET
    Malar J; 2019 May; 18(1):188. PubMed ID: 31151441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The persistence of naturally acquired antibodies and memory B cells specific to rhoptry proteins of Plasmodium vivax in patients from areas of low malaria transmission.
    Kochayoo P; Changrob S; Wangriatisak K; Lee SK; Chootong P; Han ET
    Malar J; 2019 Nov; 18(1):382. PubMed ID: 31783870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Main B-cell epitopes of PvAMA-1 and PvMSP-9 are targeted by naturally acquired antibodies and epitope-specific memory cells in acute and convalescent phases of vivax malaria.
    Soares RR; Nakaie CR; Rodrigues-da-Silva RN; da Silva RL; Lima-Junior JDC; Scopel KKG
    Parasite Immunol; 2020 May; 42(5):e12705. PubMed ID: 32096238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of Long-lived Memory B Cells specific to Duffy Binding Protein in individuals exposed to Plasmodium vivax.
    Changrob S; McHenry AM; Nyunt MH; Sattabongkot J; Han ET; Adams JH; Chootong P
    Sci Rep; 2018 May; 8(1):8347. PubMed ID: 29844379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).
    Maestre A; Muskus C; Duque V; Agudelo O; Liu P; Takagi A; Ntumngia FB; Adams JH; Sim KL; Hoffman SL; Corradin G; Velez ID; Wang R
    PLoS One; 2010 Jul; 5(7):e11437. PubMed ID: 20664684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
    Pandey JP; Morais CG; Fontes CJ; Braga EM
    Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apical membrane protein 1-specific antibody profile and temporal changes in peripheral blood B-cell populations in Plasmodium vivax malaria.
    Soares RR; Cunha CF; Ferraz-Nogueira R; Marins-Dos-Santos A; Rodrigues-da-Silva RN; da Silva Soares I; da Costa Lima-Junior J; Bertho AL; Ferreira MU; Scopel KKG
    Parasite Immunol; 2019 Sep; 41(9):e12662. PubMed ID: 31271660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
    King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody.
    Rawlinson TA; Barber NM; Mohring F; Cho JS; Kosaisavee V; Gérard SF; Alanine DGW; Labbé GM; Elias SC; Silk SE; Quinkert D; Jin J; Marshall JM; Payne RO; Minassian AM; Russell B; Rénia L; Nosten FH; Moon RW; Higgins MK; Draper SJ
    Nat Microbiol; 2019 Sep; 4(9):1497-1507. PubMed ID: 31133755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
    Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards the development of a
    De SL; Ntumngia FB; Nicholas J; Adams JH
    Expert Rev Vaccines; 2021 Feb; 20(2):97-112. PubMed ID: 33481638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunology of Plasmodium vivax malaria.
    Antonelli LR; Junqueira C; Vinetz JM; Golenbock DT; Ferreira MU; Gazzinelli RT
    Immunol Rev; 2020 Jan; 293(1):163-189. PubMed ID: 31642531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.
    de Jong RM; Tebeje SK; Meerstein-Kessel L; Tadesse FG; Jore MM; Stone W; Bousema T
    Immunol Rev; 2020 Jan; 293(1):190-215. PubMed ID: 31840844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.
    Bouillet LÉ; Dias MO; Dorigo NA; Moura AD; Russell B; Nosten F; Renia L; Braga EM; Gazzinelli RT; Rodrigues MM; Soares IS; Bruna-Romero O
    Infect Immun; 2011 Sep; 79(9):3642-52. PubMed ID: 21730090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune responses against the malaria vaccine candidate antigen Plasmodium vivax AMA-1 and IL-4 gene polymorphisms in individuals living in an endemic area of the Brazilian Amazon.
    Tomaz FM; da Cruz Furini AA; Capobianco MP; Póvoa MM; Trindade PC; Fraga VD; Conceição LM; de Azevedo LR; Oliani SM; Cassiano GC; Cavasini CE; Dos Santos SE; Machado RL
    Cytokine; 2015 Aug; 74(2):273-8. PubMed ID: 25922277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin.
    Ventocilla JA; Tapia LL; Ponce R; Franco A; Leelawong M; Aguiar JC; Baldeviano GC; Wilder BK
    Malar J; 2024 May; 23(1):163. PubMed ID: 38783317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax.
    Cao Y; Hayashi CTH; Araujo MDS; Tripathi AK; Andrade AO; Medeiros JF; Vinetz J; Kumar N
    Vaccine; 2024 Aug; 42(21):126140. PubMed ID: 39033079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multi-Stage
    McCaffery JN; Fonseca JA; Singh B; Cabrera-Mora M; Bohannon C; Jacob J; Arévalo-Herrera M; Moreno A
    Front Cell Infect Microbiol; 2019; 9():135. PubMed ID: 31119106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.